Eviendepspi® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis

World Journal of Gastroenterology

Volumn 19, Issue 34, 2013, Pages 5671-5677

  Calabrese, Carlo ^a   Praticò, Chiara ^a   Calafiore, Andrea ^a   Coscia, Maurizio ^a   Gentilini, Lorenzo ^a   Poggioli, Gilberto ^a   Gionchetti, Paolo ^a   Campieri, Massimo ^a   Rizzello, Fernando ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Duodenal polyps; Eviendep; Familial adenomatous polyposis; Ileal pouch anal anastomosis

Indexed keywords

ANTINEOPLASTIC AGENT; EVIENDEP; UNCLASSIFIED DRUG; PHYTOESTROGEN; PLANT EXTRACT;

ADULT; ANASTOMOSIS; ARTICLE; CLINCAL TRIAL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DUODENUM BIOPSY; DUODENUM POLYP; ENDOSCOPIST; FAMILIAL COLON POLYPOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEAL POUCHANAL ANASTOMOSIS; MALE; SCORING SYSTEM; SPIGELMAN SCORE; TREATMENT RESPONSE; ADOLESCENT; CLINICAL TRIAL; COLON POLYPOSIS; COLOSTOMY BAG; DIET THERAPY; DIETARY FIBER; DUODENAL POLYPS; DUODENUM DISEASE; EVIENDEP; ILEAL POUCH-ANAL ANASTOMOSIS; INTESTINE POLYP; PHYTOTHERAPY; YOUNG ADULT;

DUODENAL POLYPS; EVIENDEP; FAMILIAL ADENOMATOUS POLYPOSIS; ILEAL POUCH-ANAL ANASTOMOSIS;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; ANASTOMOSIS, SURGICAL; COLONIC POUCHES; DIETARY FIBER; DUODENAL DISEASES; FEMALE; HUMANS; INTESTINAL POLYPS; MALE; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; YOUNG ADULT;

EID: 84883857656     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i34.5671     Document Type: Article

References (43)

1. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-616 [PMID: 3039373 DOI: 10.1038/328569d0]
2. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665 [PMID: 1651562 DOI: 10.1126/sci-ence.1651562]
3. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M. Identification and characterization of the familial adeno-matous polyposis coli gene. Cell 1991; 66: 589-600 [PMID: 1651174]
4. Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999; 49: 358-364 [PMID: 10049420]
5. Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlström J, Martinsson T, Nordling M, Hultcrantz R. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001; 121: 1127-1135 [PMID: 11677205]
6. Iaquinto G, Fornasarig M, Quaia M, Giardullo N, D'Onofrio V, Iaquinto S, Di Bella S, Cannizzaro R. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc 2008; 67: 61-67 [PMID: 18155426]
7. Ruo L, Coit DG, Brennan MF, Guillem JG. Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 2002; 6: 671-675 [PMID: 12399055]
8. Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polypo-sis (FAP): results of a 10 year prospective study. Gut 2002; 50: 636-641 [PMID: 11950808]
9. Latchford AR, Neale KF, Spigelman AD, Phillips RK, Clark SK. Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2009; 7: 659-663 [PMID: 19281862]
10. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2: 783-785 [PMID: 2571019]
11. Langers AM, DeVostotNederveenCappel WH, Veenendaal RA, Bonsing BA, Hardwick JC, Vasen HF. Double balloon endoscopy for detection of small-bowel adenomas in familial adenomatous polyposis after pancreaticoduodenectomy according to Whipple. Endoscopy 2008; 40: 773-774 [PMID: 18716983]
12. Mönkemüller K, Fry LC, Ebert M, Bellutti M, Venerito M, Knippig C, Rickes S, Muschke P, Röcken C, Malfertheiner P. Feasibility of double-balloon enteroscopy-assisted chro-moendoscopy of the small bowel in patients with familial adenomatous polyposis. Endoscopy 2007; 39: 52-57 [PMID: 17252461]
13. Bülow S, Christensen IJ, Højen H, Björk J, Elmberg M, Järvinen H, Lepistö A, Nieuwenhuis M, Vasen H. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 2012; 14: 947-952 [PMID: 21973191]
14. Linsalata M, Russo F, Cavallini A, Berloco P, Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mu-cosa. Dis Colon Rectum 1993; 36: 662-667 [PMID: 8348850]
15. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000; 60: 245-248 [PMID: 10667568]
16. Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL, Remotti H, Bilinski RT, Bertagnolli MM. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res 2001; 61: 2547-2551 [PMID: 11289129]
17. Javid SH, Moran AE, Carothers AM, Redston M, Bertag-nolli MM. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer. Carcinogenesis 2005; 26: 587-595 [PMID: 15579483]
18. Seidlová-Wuttke D, Becker T, Christoffel V, Jarry H, Wuttke W. Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphy-sis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. J Steroid Biochem Mol Biol 2003; 86: 179-188 [PMID: 14568570]
19. Di Leo A, Barone M, Margiotta M. Effect of selective agonist for the estrogen receptor β (Silymarin) upon colonic cell migration in normal mice. Dig Liv Dis 2006; 38: S105
20. Kim B, Giardiello FM. Chemoprevention in familial adeno-matous polyposis. Best Pract Res Clin Gastroenterol 2011; 25: 607-622 [PMID: 22122775]
21. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offer-haus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-1316 [PMID: 8385741 DOI: 10.1056/ NEJM199305063281805]
22. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fu-jimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-1952 [PMID: 10874062 DOI: 10.1056/ NEJM200006293422603]
23. Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002; 50: 857-860 [PMID: 12010890]
24. Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdon-ald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B. Celecoxib for the prevention of colorectal ad-enomatous polyps. N Engl J Med 2006; 355: 885-895 [PMID: 16943401 DOI: 10.1056/NEJMoa061652]
25. van Engeland M, Derks S, Smits KM, Meijer GA, Herman JG. Colorectal cancer epigenetics: complex simplicity. J Clin Oncol 2011; 29: 1382-1391 [PMID: 21220596]
26. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011; 8: 686-700 [PMID: 22009203]
27. Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9: 385-391 [PMID: 18374292]
28. Sica V, Nola E, Contieri E, Bova R, Masucci MT, Medici N, Petrillo A, Weisz A, Molinari AM, Puca GA. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 1984; 44: 4670-4674 [PMID: 6467220]
29. Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, Chiumarulo C, Rizzo G, Rubino M. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987; 93: 1301-1306 [PMID: 3678749]
30. Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, Leo S. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994; 39: 2038-2042 [PMID: 8082515]
31. Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, Franceschi S. Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 329-333 [PMID: 9568789]
32. Notarnicola M, Gristina R, Messa C, Cariola F, Fiorente P, Caruso ML, Gentile M, Di Leo A. Oestrogen receptors and microsatellite instability in colorectal carcinoma patients. Cancer Lett 2001; 168: 65-70 [PMID: 11368879]
33. Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst 2001; 93: 1799-1805 [PMID: 11734596]
34. Yager JD, Liehr JG. Molecular mechanisms of estrogen car-cinogenesis. Annu Rev Pharmacol Toxicol 1996; 36: 203-232 [PMID: 8725388 DOI: 10.1146/annurev.pa.36.040196.001223]
35. Fisher B, Gunduz N, Saffer EA, Zheng S. Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res 1984; 44: 2410-2415 [PMID: 6722782]
36. Gustafsson JA. Estrogen receptor beta--a new dimension in estrogen mechanism of action. J Endocrinol 1999; 163: 379-383 [PMID: 10588810]
37. Dechering K, Boersma C, Mosselman S. Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem 2000; 7: 561-576 [PMID: 10702625]
38. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 632-640 [PMID: 11212261]
39. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 1-12 [PMID: 12476778]
40. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532 [PMID: 2841597]
41. Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, Papagni S, Guido R, Maiorano E, Ingravallo G, Comelli MC, Francavilla A, Di Leo A. Dietary-induced ERbeta up-regulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010; 31: 269-274 [PMID: 19945967]
42. Principi M, Di Leo A, Pricci M, Scavo MP, Guido R, Tanzi S, Piscitelli D, Pisani A, Ierardi E, Comelli MC, Barone M. Phy-toestrogens/insoluble fbers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study. World J Gastroenterol 2013; 19: 4325-4333 [PMID: 23885143 DOI: 10.3748/wjg.v19.i27.4325]
43. Yamada A, Watabe H, Iwama T, Obi S, Omata M, Koike K. The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule en-doscopy study. Fam Cancer 2013; Epub ahead of print [PMID: 23743563]